Extracorporeal Membrane Oxygenation for Primary Allograft Failure

Arpesella, Giorgio; Loforte, Antonio; Mikus, Elisa; Mikuš, Petr

doi:10.1016/j.transproceed.2008.06.079

Cited by 36 publications

(26 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[226][227][228][229][230][231][232][233][234][235] The majority of published data describe the relatively successful use of extracorporeal membrane oxygenation (ECMO) in cases of primary graft failure. Although 30-day mortality is reduced in those who receive ECMO, in those who survive 30 days, long-term survival appears to be comparable to those who do not have primary graft failure.…”

Section: Mechanical Circulatory Support In Amr With Hemodynamic Comprmentioning

confidence: 99%

Antibody-Mediated Rejection in Cardiac Transplantation: Emerging Knowledge in Diagnosis and Management

Colvin¹,

Cook²,

Chang³

et al. 2015

Circulation

287

251

View full text Add to dashboard Cite

Section: Mechanical Circulatory Support In Amr With Hemodynamic Comprmentioning

confidence: 99%

Antibody-Mediated Rejection in Cardiac Transplantation: Emerging Knowledge in Diagnosis and Management

Colvin¹,

Cook²,

Chang³

et al. 2015

Circulation

287

251

View full text Add to dashboard Cite

“…Timely initiation of mechanical circulatory support such as venoarterial extracorporeal membrane oxygenation (V-A ECMO) offers the possibility of survival as a bridge to recovery, surgery, implantable left ventricular assist device (LVAD) or transplantation. V-A ECMO has been beneficial in patients with acute myocardial infarction with cardiogenic shock [3,4], postcardiotomy shock [5,6], fulminant myocarditis [7,8], refractory ventricular arrhythmias [9,10], massive pulmonary embolism with right heart failure [11], right heart failure after LVAD implantation [12] and primary allograft failure [13,14]. Vascular access for V-A ECMO is achieved by central thoracic vessel cannulation or extrathoracic peripheral cannulation of the femoral and/or axillary vessels.…”

Section: Introductionmentioning

confidence: 99%

Peripheral Venoarterial Extracorporeal Membrane Oxygenation in Combination with Intra-Aortic Balloon Counterpulsation in Patients with Cardiovascular Compromise

et al. 2014

View full text Add to dashboard Cite

Objectives: Patients with profound cardiovascular compromise have poor prognosis despite inotropic and intra-aortic balloon pump (IABP) support. Peripheral venoarterial extracorporeal membrane oxygenation (V-A ECMO) offers these patients temporary support as a bridge to various options including the ‘bridge to recovery'. Methods: We studied the outcomes of 135 patients who underwent peripheral V-A ECMO and concomitant IABP implantation in our hospital from 2007 to 2012 for various clinical indications. The ECMO circuit consisted of a centrifugal pump and an oxygenator. Results: V-A ECMO was implanted in the cardiac catheterization laboratory in 51 patients (37.8%), at the bedside in 5 (3.7%) and in the operating room in 79 (58.5%). Mean duration of support was 8.5 ± 7.1 days. Median length of stay was 28 days (interquartile range 14-62). Complications included bleeding at the access site in 14.1%, stroke in 11.1% and vascular complications requiring intervention in 16.3%. Overall inhospital survival was 57.8% with outcomes including heart transplantation (3%), implantable left ventricular assist device (8.1% as bridge to transplantation and 6.7% as destination therapy), surgery (7.4%) and myocardial recovery (40.7%). Prior IABP use and axillary cannulation were independent predictors of reduced inhospital mortality, stroke or vascular injury. Conclusions: Peripheral V-A ECMO with IABP is an effective therapy for patients with severely compromised cardiovascular function. It offers reasonable survival and a spectrum of definitive options from ‘bridge to recovery' to heart transplantation for the management of this critically ill population.

show abstract

“…Существуют различные методики меха-нической поддержки трансплантированного сердца (ВАБК, одно-или двухжелудочковый обход сердца, ВА ЭКМО, катетерные осевые насосы (Impella Recover, Impella RP™ (Right Percutaneous) System) и т. п. ВА ЭКМО является одним из наиболее часто применяемых методов вспомогательного кровооб-ращения при выраженной ранней или отдаленной дисфункции сердечного трансплантата независимо от варианта расстройств центральной гемодинами-ки (бивентрикулярный, преимущественно право-или левожелудочковый) [5]. У реципиентов с ран-ней дисфункцией сердечного трансплантата для ВА ЭКМО применяют как центральную, так перифери-ческую методику канюляции [6].…”

Section: Discussionunclassified

Successful Treatment of a Recipient With Massive Thrombosis of Heart Transplant Left Chambers During Extracorporeal Membrane Oxygenation

Попцов

Захаревич

Спирина

et al. 2016

RJTAO

View full text Add to dashboard Cite

1 ФГБУ «ФНЦ трансплантологии и искусственных органов им. акад. В.И. Шумакова» Минздрава России, Москва, Российская Федерация 2 Кафедра трансплантологии и искусственных органов ГБОУ ВПО «Первый Московский государственный медицинский университет имени И.М. Сеченова» Минздрава России, Москва, Российская Федерация Представлен клинический случай успешного лечения реципиента сердца с тотальным тромбозом левого предсердия и левого желудочка, развившимся в ранние сроки после трансплантации на фоне применения периферической ВА ЭКМО как метода механической поддержки кровообращения при острой право-желудочковой недостаточности пересаженного сердца. Пациенту успешно выполнили хирургическую тромбэктомию, и ВА ЭКМО прекращена на первые сутки после операции.Ключевые слова: трансплантация сердца, экстракорпоральная мембранная оксигенация, тромбоз левого желудочка, активированное время свертывания. We present a case report of a 16-year-old man with venoarterial extracorporeal membrane oxygenation (VA-ECMO) for primary graft failure after orthotopic heart transplantation who developed left atrium and left ventricular thrombosis despite systemic anticoagulation. The surgical thrombectomy was performed and the patient was successfully weaned off the extracorporeal support on the fi rst day thereafter. SUCCESSFUL TREATMENT OF A RECIPIENT WITH MASSIVE THROMBOSIS OF HEART TRANSPLANT LEFT CHAMBERS DURING EXTRACORPOREAL MEMBRANE OXYGENATION

show abstract

Extracorporeal Membrane Oxygenation for Primary Allograft Failure

Cited by 36 publications

References 2 publications

Antibody-Mediated Rejection in Cardiac Transplantation: Emerging Knowledge in Diagnosis and Management

Antibody-Mediated Rejection in Cardiac Transplantation: Emerging Knowledge in Diagnosis and Management

Peripheral Venoarterial Extracorporeal Membrane Oxygenation in Combination with Intra-Aortic Balloon Counterpulsation in Patients with Cardiovascular Compromise

Successful Treatment of a Recipient With Massive Thrombosis of Heart Transplant Left Chambers During Extracorporeal Membrane Oxygenation

Contact Info

Product

Resources

About